Who owns Kalvista Pharmaceuticals?
- Ticker: KALV
- CUSIP Number: 483497103
Tip: Access positions for across all investors
Analyze quarterly positions in Kalvista Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Kalvista Pharmaceuticals stock
Who bought or sold Kalvista Pharmaceuticals this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
VR Adviser | 6.2M | $74M | 53% | Mar 2024 |
|
Suvretta Capital Management | 4.2M | $50M | 73% | Mar 2024 |
|
Tang Capital Management | 4.1M | $49M | 20% | Mar 2024 |
|
Frazier Life Sciences Management | 3.7M | $44M | 2% | Mar 2024 |
|
Adage Capital Partners GP | 2.6M | $31M | 144% | Mar 2024 |
|
BlackRock | 2.4M | $29M | 48% | Mar 2024 |
|
Vanguard Group | 1.7M | $20M | -5% | Mar 2024 |
|
Boxer Capital | 1.6M | $19M | -4% | Mar 2024 |
|
Saturn V Capital Management | 1.4M | $17M | -20% | Mar 2024 |
|
First Turn Management | 1.2M | $14M | 100% | Mar 2024 |
|
DAFNA Capital Management | 807k | $9.6M | 34% | Mar 2024 |
|
MPM Oncology Impact Management | 761k | $9.0M | 32% | Mar 2024 |
|
Emerald Advisers | 671k | $8.0M | 100% | Mar 2024 |
|
Geode Capital Management | 652k | $7.7M | 25% | Mar 2024 |
|
Marshall Wace | 629k | $7.5M | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 580k | $6.9M | -19% | Mar 2024 |
|
Emerald Mutual Fund Advisers, Trust | 529k | $6.3M | 100% | Mar 2024 |
|
Perceptive Advisors | 500k | $5.9M | 100% | Mar 2024 |
|
Morgan Stanley | 424k | $5.0M | 102% | Mar 2024 |
|
Soleus Capital Management | 386k | $4.6M | 100% | Mar 2024 |
|
Candriam Luxembourg S.C.A. | 350k | $4.2M | 100% | Mar 2024 |
|
Jane Street | 344k | $4.1M | 818% | Mar 2024 |
|
Northern Trust | 318k | $3.8M | 15% | Mar 2024 |
|
Rosalind Advisors | 288k | $3.4M | -4% | Mar 2024 |
|
Citigroup | 283k | $3.4M | 0% | Mar 2024 |
|
Two Sigma Investments | 192k | $2.3M | 16% | Mar 2024 |
|
Qube Research & Technologies | 179k | $2.1M | 100% | Mar 2024 |
|
Woodline Partners | 151k | $1.8M | 100% | Mar 2024 |
|
Two Sigma Advisers | 146k | $1.7M | -28% | Mar 2024 |
|
Citadel Advisors | 133k | $1.6M | -85% | Mar 2024 |
|
AlphaCentric Advisors | 130k | $1.5M | -4% | Mar 2024 |
|
Walleye Trading Advisors | 120k | $1.4M | 23% | Mar 2024 |
|
Bank of New York Mellon | 112k | $1.3M | 11% | Mar 2024 |
|
Susquehanna International | 109k | $1.3M | -42% | Mar 2024 |
|
Jpmorgan Chase & Co | 91k | $1.1M | 238% | Mar 2024 |
|
D. E. Shaw & Co | 87k | $1.0M | -2% | Mar 2024 |
|
UBS O'Connor | 82k | $973k | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 78k | $927k | -3% | Mar 2024 |
|
Nuveen Asset Management | 71k | $843k | 17% | Mar 2024 |
|
Zimmer Partners | 70k | $830k | 100% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 68k | $809k | -39% | Mar 2024 |
|
Goldman Sachs Group | 60k | $710k | -82% | Mar 2024 |
|
ClariVest Asset Management | 56k | $659k | 100% | Mar 2024 |
|
Healthcare Of Ontario Pension Plan Trust Fund | 52k | $631k | -63% | Dec 2023 |
|
FMR | 51k | $604k | -12% | Mar 2024 |
|
Rhumbline Advisers | 47k | $561k | 4% | Mar 2024 |
|
State of Wisconsin Investment Board | 45k | $534k | -12% | Mar 2024 |
|
PDT Partners | 42k | $498k | 100% | Mar 2024 |
|
Skandinaviska Enskilda Banken AB | 41k | $483k | 100% | Mar 2024 |
|
New York State Common Retirement Fund | 39k | $459k | 290% | Mar 2024 |
|
Leucadia National Corporation | 35k | $415k | -97% | Mar 2024 |
|
American Century Companies | 33k | $388k | 48% | Mar 2024 |
|
Superstring Capital Management | 32k | $380k | 100% | Mar 2024 |
|
HighVista Strategies | 32k | $378k | 100% | Mar 2024 |
|
Alliancebernstein | 30k | $368k | -7% | Dec 2023 |
|
UBS Group | 29k | $337k | 5% | Mar 2024 |
|
Bank of America Corporation | 24k | $284k | -26% | Mar 2024 |
|
Legato Capital Management | 24k | $281k | 100% | Mar 2024 |
|
T. Rowe Price Associates | 22k | $263k | 4% | Mar 2024 |
|
Barclays | 22k | $260k | -48% | Mar 2024 |
|
Lincoln National | 21k | $245k | 100% | Mar 2024 |
|
Oxford Asset Management | 21k | $245k | 100% | Mar 2024 |
|
Millennium Management | 19k | $229k | -61% | Mar 2024 |
|
Rathbones Brothers | 19k | $226k | 0% | Mar 2024 |
|
Susquehanna Portfolio Strategies | 18k | $218k | 100% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 18k | $214k | 94% | Mar 2024 |
|
MetLife Investment Advisors | 17k | $206k | 34% | Dec 2023 |
|
Susquehanna Fundamental Investments | 16k | $192k | 100% | Mar 2024 |
|
American International | 15k | $189k | 25% | Dec 2023 |
|
Deerfield Management Company | 15k | $182k | 100% | Mar 2024 |
|
Wells Fargo & Company | 15k | $173k | 34% | Mar 2024 |
|
ExodusPoint Capital Management | 15k | $172k | -58% | Mar 2024 |
|
Schonfeld Strategic Advisors | 13k | $152k | 100% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 12k | $145k | 6% | Mar 2024 |
|
SG Americas Securities | 12k | $143k | -91% | Mar 2024 |
|
Ironwood Investment Management | 12k | $136k | 100% | Mar 2024 |
|
Mirae Asset Global Investments | 11k | $72k | 4% | Mar 2024 |
|
AQR Capital Management | 11k | $125k | 100% | Mar 2024 |
|
Ing Investment Management | 10k | $122k | -1% | Mar 2024 |
|
Principal Financial Group | 10k | $121k | -11% | Mar 2024 |
|
Entropy Technologies | 10k | $121k | 100% | Mar 2024 |
|
Campbell & Co. Investment Adviser | 10k | $119k | 100% | Mar 2024 |
|
Choate Investment Advisors | 10k | $119k | 0% | Mar 2024 |
|
ADAR1 Capital Management | 10k | $119k | 100% | Mar 2024 |
|
China Universal Asset Management | 8.0k | $95k | 102% | Mar 2024 |
|
NISA Investment Advisors | 4.4k | $52k | 0% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.6k | $42k | 100% | Mar 2024 |
|
Simplex Trading | 3.4k | $40k | 100% | Mar 2024 |
|
California State Teachers Retirement System | 3.1k | $37k | -42% | Mar 2024 |
|
Legal & General Group | 2.6k | $31k | 0% | Mar 2024 |
|
Summit Investment Advisors | 2.5k | $29k | 0% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.8k | $22k | 35% | Dec 2023 |
|
Quest Partners | 1.8k | $21k | 100% | Mar 2024 |
|
Zurcher Kantonalbank | 1.5k | $18k | 100% | Mar 2024 |
|
Amalgamated Bank | 1.1k | $13k | -49% | Mar 2024 |
|
Quarry | 1.0k | $12k | 100% | Mar 2024 |
|
Royal Bank of Canada | 702.00 | $0 | -93% | Mar 2024 |
|
Brian McDonald | 519.00 | $6.2k | -5% | Mar 2024 |
|
Group One Trading | 414.00 | $4.9k | -97% | Mar 2024 |
|
Signature | 198.00 | $2.3k | 0% | Mar 2024 |
|
Red Tortoise | 187.00 | $2.2k | 0% | Mar 2024 |
|
Tower Research Capital | 166.00 | $2.0k | -94% | Mar 2024 |
|
Daiwa Securities Group | 154.00 | $2.0k | 100% | Mar 2024 |
|
Quadrant Capital | 81.00 | $961.000200 | 100% | Mar 2024 |
|
GAMMA Investing | 16.00 | $190.000000 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $59.000000 | 100% | Mar 2024 |
|
Fortitude Family Office | 3.00 | $36.000000 | 0% | Mar 2024 |
|
Who sold out of Kalvista Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Caption Management | Dec 2023 | 887k | $11M |
Vivo Capital | Dec 2023 | 856k | $11M |
First Manhattan | Sep 2023 | 393k | $3.8M |
Opaleye Management | Dec 2023 | 150k | $1.8M |
Cibc World Markets | Sep 2023 | 50k | $482k |
Boothbay Fund Management | Sep 2023 | 31k | $297k |
ALPS Advisors | Sep 2023 | 25k | $244k |
LMR Partners | Dec 2023 | 25k | $306k |
Algert Coldiron Investors | Sep 2023 | 23k | $224k |
Walleye Trading | Dec 2023 | 20k | $244k |
Cubist Systematic Strategies | Dec 2023 | 15k | $181k |
Belvedere Trading | Sep 2023 | 15k | $139k |
Balyasny Asset Management | Dec 2023 | 12k | $146k |
Springbok Capital Management | Sep 2023 | 11k | $103k |
Bridgeway Capital Management | Sep 2023 | 11k | $101k |
Jump Financial | Sep 2023 | 10k | $98k |
Natixis | Sep 2023 | 5.0k | $48k |
AJOVista | Dec 2023 | 4.9k | $60k |
Quantbot Technologies | Sep 2023 | 3.2k | $31k |
Garner Asset Management Corp | Dec 2023 | 135.00 | $2.0k |
Pnc Financial Services | Dec 2023 | 5.00 | $61.000000 |